Consumers Union

Voluntary advertising plan won't cut it, consumer group says

Published in Pharma Law Weekly, August 16th, 2005

The recent announcement by the pharmaceutical trade association of "voluntary principles" for direct-to-consumer advertising is a placebo that will have little impact on informing consumers about the real effectiveness of drugs or their possible safety risks, Consumers Union says.

"It appears the pharmaceutical industry has produced a placebo rather than supporting real reform of drug advertising," said Rob Schneider, director of Consumers Union's prescription drug reform effort, www.PrescriptionForChange.org.

"Much of what the industry is proposing is already law, such as producing ads that aren't misleading," Schneider said. "What we clearly need...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry